This overview will demonstrate that cough is a common and potentially expensive healthcare problem. Improvement in the quality of care of those with cough has been the focus of study for a variety of disciplines in medicine. The purpose of the Cough Guideline and Expert
In neurophysiologic and acoustical terms, cough arises following activation of a complex sensorimotor refl ex arc whose sound can be easily identifi ed by the human ear. Th e distinctive sound is generated by the explosive release of trapped and pressurized intrathoracic air from the sudden opening of the vocal folds. 1 Because cough is an easily described and recognizable physical act, patients know what is being referred to as cough, thereby lending
Editor's Note: Th is is the fi rst of a series of articles that is part of the CHEST Organization's update of its 2006 Evidence-Based Clinical Practice Guidelines on the Diagnosis and Management of Cough. You may have already seen it online ahead of print. Th e subject matter that will comprise this new Cough Guideline and Expert
Panel Report is tabulated in this article. While this article and selected others will appear in print as well as online, look for the entire spectrum of topics that will be progressively updated online during the course of the coming months to several years. credibility to fi ndings from patient surveys on prevalence of cough. Th is has also enabled investigators to develop coughspecifi c, patient-reported outcome tools by which physicians can assess the impact of cough on patients. Moreover, because the sound resulting from coughing has a typical acoustic waveform profi le, soft ware detection algorithms for automatic monitoring 2 have been developed for cough counting.
While cough in healthy individuals is physiologically important, it typically is of little clinical importance because it is normally a very uncommon event. 3 , 4 Nevertheless, it assumes great importance as (1) a defense mechanism when it helps clear excessive secretions and foreign material from the airways, (2) a factor in the spread of infection, (3) a patient-initiated tactic to provide cardiopulmonary resuscitation to maintain consciousness during a potentially lethal arrhythmia and/or convert arrhythmias to a normal rhythm, 5 , 6 and (4) a common symptom for which patients seek medical attention. While we acknowledge that cough can be viewed from a variety of perspectives, the focus of this update of the 2006 guidelines 7 will be on managing cough as a symptom and when its defense mechanism function has been impaired. Moreover, while the majority of topics in this update will be written to aid practicing clinicians in a variety of disciplines, as well as patients, other topics such as those that appear in Table 1 also target basic and clinical researchers as the intended users.
Th e Importance of Cough
Recognition by the American College of Chest Physicians (CHEST) of the importance of cough in clinical practice in the United States was the impetus for developing the fi rst evidence-based cough guideline, published in 1998. 8 Since then, and the publication of the second edition in 2006, 7 the impact of cough on global health has attained widespread recognition. Published cough guidelines, albeit of varying quality and foci (eg, adults, pediatrics, acute cough, chronic cough, cough in palliative care), have been developed by organizations not only from the United States 7 but also from Australia, 9 Belgium, 10 Brazil, 11 China, 12 Germany, 13 United Kingdom, 14 Ireland, 15 Netherlands, 16 Japan, 17 South Africa, 18 and Spain. 19 Prevalence data from Australia, Great Britain , Japan, and the United States provide the putative reason for the widespread interest in developing cough guidelines. Government-generated statistics from Australia 20 and the United States 21 reveal that cough of undiff erentiated duration is the single most common complaint for which patients of all ages seek medical care from primary care physicians in the ambulatory setting. Surveys in Japan 22 and Great Britain 23 suggest that the prevalence of chronic cough in the general population is 10.2% and 12%, respectively. Further, fi nancial data derived from the over-the-counter market for cough and cold remedy products that are of doubtful benefi t and potentially harmful for young children 7 support the statistics that cough is a very troublesome symptom. According to a survey conducted for the CHEST Expert Cough Panel in US dollars by Th e Nielsen Company, 24 While these countrywide fi gures are large, especially in the United States, they greatly underestimate the total cost of treating cough. Th ey do not refl ect the total economic burden of direct costs that include the physician fees, radiographs, and laboratory testing, and the cost of prescription drugs for the myriad causes of cough other than the common cold and indirect costs, such as time missed from work.
In its deliberations regarding how to update the second edition of these guidelines and advance the fi eld, the Expert Panel unanimously decided to cover the same comprehensive spectrum of topics (Table 1) , albeit in a diff erent order, to keep the publication up to date and clinically useful, while doing so according to the more rigorous, evidence-based methodologies 25 that have evolved since the last publication. 7 While the panelists believed that all clinically important topics would be covered in this update, they not only acknowledged that the fi nal titles of topics listed in Table 1 might be modifi ed but also knew that they would be able to add additional ones should the need arise, because the update would be an evolving process developed over time. To satisfy all of these objectives, even when the evidence on some topics was not robust enough for guideline recommendations, the Expert Panel sought and received approval from the CHEST organization's Guidelines Oversight Committee for creating a hybrid model for providing advice regarding the diagnosis and management of cough. Th is current publication is a product of this hybrid model; it provides a combination of recommendations derived from clinical practice guideline methodology and suggestions derived from consensus statement methodology (one component of which is a modifi ed Delphi process for consensus achievement). 26 Th e specifi cs of how this was accomplished are described in the methodology article in this report. 26 Moreover, to keep this publication and all guidelines as current as possible, the CHEST organization has developed and implemented its "living guidelines" model, 25 , 27 whereby topics are reviewed for possible updating on an annual basis, and when new evidence or interventions demand it, they are updated. To avoid delays in publishing, these updates will be added to the literature as soon as updates are finalized, and the full scope of topics, in their entirety, will appear over a 4-year period.
In addition to these advances, the current set of topics focuses on the concept of intervention fi delity, 28 because the lack of attention to it may help explain some of the varying successes in treating chronic cough that have been reported in the literature. Intervention fi delity is the "extent to which an intervention was delivered as conceived and planned to arrive at valid conclusions concerning its eff ectiveness in achieving target outcomes. " 29 Because of the importance of this concept, the Expert Panel suggests that it be included in the design of Pharmacologic protussive therapy a While cough due to many conditions such as asthma and aspiration will be discussed in the chronic category, these conditions can present acutely and subacutely. Nevertheless, the same principles of management apply once the diagnosis is made.
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studies of cough and how it might be addressed to prospectively avoid and assess the problem (R. S. I. and C. T. F., unpublished data, 2014).
As cough is a global problem managed by a variety of disciplines, these guidelines and the Expert Panel Report represent the interprofessional, collaborative eff orts of an international group of 53 individuals from the fi elds of adult and pediatric pulmonology and respirology, internal medicine and family medicine, allergy, psychology, neurology, adult and pediatric speech pathology, otolaryngology, gastroenterology, gerontology, infectious disease, nursing, anatomy, physiology, thoracic oncology, palliative care, and pharmacy. Methodologists and representatives for lay consumers and the US Food and Drug Administration also served on the Panel and provided invaluable insights.
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